Effective Treatment With Everolimus for Recurrent Granulomatous Interstitial Nephritis in a Renal Transplant Recipient: A Case Report.

Abstract

BACKGROUND:

Granulomatous interstitial nephritis (GIN) is a rare renal disease, and its etiology remains unknown. We report recurrent GIN in renal allograft successfully treated with everolimus (EVR).

CASE REPORT:

A 22-year-old man with GIN received a kidney from his mother. On follow-up 8 months later, his serum creatinine level was increased, from 1.3 mg/dL to 1.7 mg/dL, and he had microhematuria and proteinuria. A protocol graft biopsy at 1 year after transplantation showed epithelioid granuloma with multinucleated giant cells. He received steroid pulse therapy for recurrent GIN twice, but he developed allograft dysfunction, hematuria, and proteinuria. EVR was started in combination with maintenance immunosuppressants at 28 months after transplantation. Thereafter, the serum creatinine level decreased, from 2.1 mg/dL to 1.6 mg/dL, and microhematuria and proteinuria were stable despite reduction of steroid dose.

CONCLUSIONS:

Maintenance immunosuppressive therapy combined with EVR may be effective for the recurrence of idiopathic GIN in renal allograft.

• Authors: J Teranishi, Y Hattori, T Mochizuki, T Kawahara, K Makiyama, H Uemura
• Journal: Transplantation proceedings (Transplant Proc) Vol. 48 Issue 3 Pg. 946-8 (Apr 2016) ISSN: 1873-2623 [Electronic] United States
• PMID: 27234775 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2016 Elsevier Inc. All rights reserved.

Chemical References

• Immunosuppressive Agents
• Everolimus

Topics

• Biopsy
• Everolimus (therapeutic use)
• Humans
• Immunosuppression Therapy (adverse effects)
• Immunosuppressive Agents (therapeutic use)
• Kidney (pathology)
• Kidney Transplantation (adverse effects)
• Male
• Nephritis, Interstitial (diagnosis, drug therapy, etiology)
• Recurrence
• Transplant Recipients
• Transplantation, Homologous (adverse effects)
• Treatment Outcome
• Young Adult